{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:31:19Z","timestamp":1792132279346,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002992","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The RTS,S\/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study seeks to identify whether vaccination could reach additional children who are at risk from malaria but do not currently have access to, or use, core malaria interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using data from household surveys, the overlap between malaria intervention coverage and childhood vaccination (diphtheria-tetanus-pertussis dose 3, DTP3) uptake in 20 African countries with at least one first administrative level unit with\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      parasite prevalence greater than 10% was calculated. Multilevel logistic regression was used to explore patterns of overlap by demographic and socioeconomic variables. The public health impact of delivering RTS,S\/AS01 to those children who do not use an insecticide-treated net (ITN), but who received the DTP3 vaccine, was also estimated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Uptake of DTP3 was higher than malaria intervention coverage in most countries. Overall, 34% of children did not use ITNs and received DTP3, while 35% of children used ITNs and received DTP3, although this breakdown varied by country. It was estimated that there are 33 million children in these 20 countries who do not use an ITN. Of these, 23 million (70%) received the DTP3 vaccine. Vaccinating those 23 million children who receive DTP3 but do not use an ITN could avert up to an estimated 9.7 million (range 8.5\u201310.8 million) clinical malaria cases each year, assuming all children who receive DTP3 are administered all four RTS,S doses. An additional 10.8 million (9.5\u201312.0 million) cases could be averted by vaccinating those 24 million children who receive the DTP3 vaccine and use an ITN. Children who had access to or used an ITN were 9\u201313% more likely to reside in rural areas compared to those who had neither intervention regardless of vaccination status. Mothers\u2019 education status was a strong predictor of intervention uptake and was positively associated with use of ITNs and vaccination uptake and negatively associated with having access to an ITN but not using it. Wealth was also a strong predictor of intervention coverage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Childhood vaccination to prevent malaria has the potential to reduce inequity in access to existing malaria interventions and could substantially reduce the childhood malaria burden in sub-Saharan Africa, even in regions with lower existing DTP3 coverage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-021-03966-x","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:04:28Z","timestamp":1637125468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-4003","authenticated-orcid":false,"given":"H. Juliette T.","family":"Unwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazaro","family":"Mwandigha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Winskill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra C.","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6271-9921","authenticated-orcid":false,"given":"Alexandra B.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"3966_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207\u201311.","journal-title":"Nature"},{"key":"3966_CR2","unstructured":"WHO. World malaria report 2020. Geneva, World Health Organization, 2020. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2020. Accessed 18 Jul 2019."},{"key":"3966_CR3","unstructured":"WHO. Global technical strategy for malaria, 2016\u20132030. Geneva, World Health Organization, 2015. https:\/\/www.who.int\/malaria\/publications\/atoz\/9789241564991\/en\/. Accessed 18 Jul 2019."},{"key":"3966_CR4","volume-title":"High burden to high impact: a targeted malaria response","author":"WHO","year":"2018","unstructured":"WHO. High burden to high impact: a targeted malaria response. Geneva: World Health Organization; 2018."},{"key":"3966_CR5","volume-title":"World malaria report 2017","author":"WHO","year":"2017","unstructured":"WHO. World malaria report 2017. Geneva: World Health Organization; 2017."},{"key":"3966_CR6","volume-title":"World malaria report 2019","author":"WHO","year":"2019","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019."},{"key":"3966_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.vaccine.2016.11.042","volume":"35","author":"K Galactionova","year":"2017","unstructured":"Galactionova K, Tediosi F, Camponovo F, Smith TA, Gething PW, Penny MA. Country specific predictions of the cost-effectiveness of malaria vaccine RTS, S\/AS01 in endemic Africa. Vaccine. 2017;35:53\u201360.","journal-title":"Vaccine"},{"key":"3966_CR8","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1016\/S2214-109X(18)30059-7","volume":"6","author":"F Chao","year":"2018","unstructured":"Chao F, You D, Pedersen J, Hug L, Alkema L. Articles National and regional under-5 mortality rate by economic status for low-income and middle-income countries\u202f: a systematic assessment. Lancet Glob Health. 2018;6:e535\u201347.","journal-title":"Lancet Glob Health"},{"key":"3966_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S1473-3099(05)70269-3","volume":"5","author":"J Webster","year":"2005","unstructured":"Webster J, Lines J, Bruce J, Armstrong-Schellenberg J, Hanson K. Which delivery systems reach the poor? Equity of treated nets, untreated nets and immunisation to reduce child mortality in Africa. Lancet Infect Dis. 2005;5:709\u201317.","journal-title":"Lancet Infect Dis"},{"key":"3966_CR10","doi-asserted-by":"publisher","first-page":"1408385","DOI":"10.1080\/16549716.2017.1408385","volume":"10","author":"Z Li","year":"2017","unstructured":"Li Z, Li M, Subramanian SV, Lu C. Assessing levels and trends of child health inequality in 88 developing countries: from 2000 to 2014. Glob Health Action. 2017;10:1408385.","journal-title":"Glob Health Action"},{"key":"3966_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2471\/BLT.07.040089","volume":"86","author":"FE Andre","year":"2008","unstructured":"Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86:140\u20136.","journal-title":"Bull World Health Organ"},{"key":"3966_CR12","doi-asserted-by":"publisher","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","volume":"369","author":"B Greenwood","year":"2014","unstructured":"Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc B. 2014;369:20130433.","journal-title":"Philos Trans R Soc B"},{"key":"3966_CR13","unstructured":"Gavi The Vaccine Alliance. Gavi in Africa since 2000. Geneva. 2020. https:\/\/www.gavi.org. Accessed 18 Jul 2019."},{"key":"3966_CR14","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/S2214-109X(16)30141-3","volume":"4","author":"AR Hosseinpoor","year":"2016","unstructured":"Hosseinpoor AR, Bergen N, Schlotheuber A, Gacic-Dobo M, Hansen PM, Senouci K, et al. State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household health surveys. Lancet Glob Health. 2016;4:e617\u201326.","journal-title":"Lancet Glob Health"},{"key":"3966_CR15","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.vaccine.2017.03.029","volume":"35","author":"C Arsenault","year":"2017","unstructured":"Arsenault C, Johri M, Nandi A, Mendoza JM, Hansen PM, Harper S. Country-level predictors of vaccination coverage and inequalities in Gavi-supported countries. Vaccine. 2017;35:2479\u201388.","journal-title":"Vaccine"},{"key":"3966_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-019-1656-7","volume":"575","author":"P Piot","year":"2019","unstructured":"Piot P, Larson HJ, Brien KLO, John N, Ng E, Sow S, et al. Immunization: vital progress, unfinished agenda. Nature. 2019;575:119\u201329.","journal-title":"Nature"},{"key":"3966_CR17","first-page":"33","volume":"4","author":"WHO","year":"2016","unstructured":"WHO. Malaria vaccine: WHO position paper\u2013January 2016. Wkly Epidemiol Rec. 2016;4:33\u201352.","journal-title":"Wkly Epidemiol Rec"},{"key":"3966_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"RTSS Clinical Trials Partnership","year":"2015","unstructured":"RTSS Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31\u201345.","journal-title":"Lancet"},{"key":"3966_CR19","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(19)30937-7","volume":"393","author":"P Adepoju","year":"2019","unstructured":"Adepoju P. RTS,S malaria vaccine pilots in three African countries. Lancet. 2019;393:1685.","journal-title":"Lancet"},{"key":"3966_CR20","unstructured":"Hamel MJ. Malaria vaccine implementation programme (MVIP) update and framework for policy decision. 2018."},{"key":"3966_CR21","unstructured":"ICF. Data. The DHS program website. Funded by USAID. https:\/\/dhsprogram.com. Accessed 18 Jul 2019."},{"key":"3966_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0140-6736(19)31097-9","volume":"394","author":"DJ Weiss","year":"2019","unstructured":"Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, Bisanzio D, Battle KE, et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000\u201317: a spatial and temporal modelling study. Lancet. 2019;394:322\u2013411.","journal-title":"Lancet"},{"key":"3966_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(15)00725-4","volume":"387","author":"MA Penny","year":"2016","unstructured":"Penny MA, Verity R, Bever CA, Sauboin C, Galactionova K, Flasche S, et al. Public health impact and cost-effectiveness of the RTS,S\/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet. 2016;387:367\u201375.","journal-title":"Lancet"},{"key":"3966_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.12688\/wellcomeopenres.15311.1","volume":"4","author":"OJ Watson","year":"2019","unstructured":"Watson OJ, FitzJohn R, Eaton JW. rdhs: an R package to interact with The Demographic and Health Surveys (DHS) Program datasets. Wellcome Open Res. 2019;4:103.","journal-title":"Wellcome Open Res"},{"key":"3966_CR25","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/sim.1522","volume":"22","author":"D Hedeker","year":"2003","unstructured":"Hedeker D. A mixed-effects multinomial logistic regression model. Stat Med. 2003;22:1433\u201346.","journal-title":"Stat Med"},{"key":"3966_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1471082X0100100201","volume":"1","author":"J Hartzel","year":"2001","unstructured":"Hartzel J, Agresti A, Caffo B. Multinomial logit random effects models. Stat Modelling. 2001;1:81\u2013102.","journal-title":"Stat Modelling"},{"key":"3966_CR27","unstructured":"SAS Institute Inc. SAS 9.4 for windows."},{"key":"3966_CR28","unstructured":"United Nations. World population prospects\u2014population division\u2014United Nations. 2019. https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/. Accessed 17 Jul 2019."},{"key":"3966_CR29","unstructured":"CIESIN. Gridded population of the world (GPW), v4|SEDAC. https:\/\/beta.sedac.ciesin.columbia.edu\/data\/collection\/gpw-v4. Accessed 4 May 2021."},{"key":"3966_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12936-018-2500-5","volume":"17","author":"DA Pfeffer","year":"2018","unstructured":"Pfeffer DA, Lucas TCD, May D, Harris J, Rozier J, Twohig KA, et al. MalariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project. Malar J. 2018;17:352.","journal-title":"Malar J"},{"key":"3966_CR31","unstructured":"WHO. Q&A on the malaria vaccine implementation programme (MVIP). Geneva, World Health Organization. 2019. https:\/\/www.who.int\/malaria\/media\/malaria-vaccine-implementation-qa\/en\/. Accessed 17 Jul 2019."},{"key":"3966_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000324","volume":"7","author":"JT Griffin","year":"2010","unstructured":"Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med. 2010;7: e1000324.","journal-title":"PLoS Med"},{"key":"3966_CR33","unstructured":"WHO. World Malaria Report 2018. Geneva, World Health Organization, 2018. https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/en\/. Accessed 18 Jul 2019."},{"key":"3966_CR34","unstructured":"Gavi The Vaccine Alliance. Facts and figures. 2019. https:\/\/www.gavi.org\/programmes-impact\/our-impact\/facts-and-figures. Accessed 18 Jul 2019."},{"key":"3966_CR35","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1086\/496887","volume":"192","author":"L Meerman","year":"2005","unstructured":"Meerman L, Ord R, Bousema JT, van Niekerk M, Osman E, Hallett R, et al. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J Infect Dis. 2005;192:1651\u20137.","journal-title":"J Infect Dis"},{"key":"3966_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217262","volume":"14","author":"A Mpimbaza","year":"2019","unstructured":"Mpimbaza A, Nayiga S, Ndeezi G, Rosenthal PJ, Karamagi C, Katahoire A. Understanding the context of delays in seeking appropriate care for children with symptoms of severe malaria in Uganda. PLoS ONE. 2019;14: e0217262.","journal-title":"PLoS ONE"},{"key":"3966_CR37","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1016\/j.vaccine.2020.04.031","volume":"38","author":"GJ Bell","year":"2020","unstructured":"Bell GJ, Loop M, Topazian HM, Hudgens M, Mvalo T, Juliano JJ, et al. Case reduction and cost-effectiveness of the RTS, S\/AS01 malaria vaccine alongside bed nets in Lilongwe, Malawi. Vaccine. 2020;38:4079\u201387.","journal-title":"Vaccine"},{"key":"3966_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12913-018-3270-z","volume":"18","author":"P Binyaruka","year":"2018","unstructured":"Binyaruka P, Borghi J. Validity of parental recalls to estimate vaccination coverage: evidence from Tanzania. BMC Health Serv Res. 2018;18:440.","journal-title":"BMC Health Serv Res"},{"key":"3966_CR39","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.vaccine.2012.10.089","volume":"31","author":"M Miles","year":"2013","unstructured":"Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine. 2013;31:1560\u20138.","journal-title":"Vaccine"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03966-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-021-03966-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-021-03966-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:13:56Z","timestamp":1637126036000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-021-03966-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3966"],"URL":"https:\/\/doi.org\/10.1186\/s12936-021-03966-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.09.20209973","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"438"}}